Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kent, David M, Rothwell, Peter M, Ioannidis, John PA, Altman, Doug G, Hayward, Rodney A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928211/
https://www.ncbi.nlm.nih.gov/pubmed/20704705
http://dx.doi.org/10.1186/1745-6215-11-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928211/
https://www.ncbi.nlm.nih.gov/pubmed/20704705
http://dx.doi.org/10.1186/1745-6215-11-85

Ejemplares similares